文献速递免疫规划妇幼与学校卫生卫生政策与健康促进

孕妇与同居伴侣对孕产妇RSV疫苗接种的认知与支持配对调查

Partner awareness and support for maternal RSV vaccination: a paired survey of pregnant women and co-residing partners in Japan.
PubMed 文献 · Vaccine · 2026-07-16

本研究于日本常规免疫规划引入孕产妇RSV疫苗前,对100对孕妇及其同居伴侣进行配对网络横断面调查。孕妇对疫苗详细认知率高于伴侣(66.0% vs 22.0%),伴侣支持接种(aOR 11.17)和伴侣详细认知(aOR 4.98)与孕妇积极接种意愿独立相关。

要点

  • 孕妇对孕产妇RSV疫苗的详细认知率(66.0%)显著高于同居伴侣(22.0%)。
  • 伴侣支持接种与孕妇积极接种意愿独立相关(aOR 11.17,95%CI 3.66-34.07)。
  • 伴侣详细认知亦与孕妇积极接种意愿独立相关(aOR 4.98,95%CI 1.13-21.92)。

核心结论

  • 伴侣支持与伴侣认知均与孕妇对孕产妇RSV疫苗的积极接种意愿独立相关,但伴侣认知水平远低于孕妇。

研究设计与样本

  • 2026年3月13日至19日开展的全国性网络横断面调查,纳入妊娠28-36周孕妇及其同居伴侣,通过Rakuten Insight面板获得100对家庭配对数据。

主要发现

  • 孕妇对孕产妇RSV疫苗的详细认知率为66.0%,伴侣为22.0%。
  • 在详细认知的孕妇中,72.7%表现出积极接种意愿。
  • 家庭内对RSV及孕产妇RSV疫苗详细认知的一致性低(κ分别为0.144和0.220),不一致主要源于仅孕妇认知。
  • 多变量分析显示,伴侣支持接种的调整OR为11.17(95%CI 3.66-34.07),伴侣详细认知的调整OR为4.98(95%CI 1.13-21.92)。

临床怎么用

  • 实施策略应将同居伴侣作为家庭决策的关键参与者纳入,以提高孕产妇RSV疫苗接种意愿。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Maternal respiratory syncytial virus (RSV) vaccination was introduced into Japan's routine immunization program in April 2026. This study examined vaccine acceptance and household-level factors, including co-residing partner awareness and support, immediately before program introduction. METHODS: We conducted a nationwide web-based cross-sectional survey of pregnant women at 28-36 weeks of gestation and their co-residing partners from March 13 to 19, 2026. Paired data were obtained from 100 household pairs through the Rakuten Insight panel. The primary outcome was positive maternal RSV vaccine acceptance, defined as being vaccinated, planning vaccination, or intending vaccination. Associated factors were examined using logistic regression. RESULTS: Detailed awareness of the maternal RSV vaccine was higher among pregnant women than partners (66.0% vs. 22.0%). Among women with detailed awareness, 72.7% showed positive acceptance. Within-household agreement on detailed RSV and maternal RSV vaccine awareness was low (κ = 0.144 and κ = 0.220, respectively), with discordance mainly reflecting pregnant woman-only awareness. In multivariable analysis, partner support for vaccination (adjusted OR 11.17, 95% CI 3.66-34.07) and detailed partner awareness (adjusted OR 4.98, 95% CI 1.13-21.92) were independently associated with positive acceptance. CONCLUSIONS: Partner support and awareness were independently associated with maternal RSV vaccine acceptance, although partner awareness was substantially lower than pregnant women's awareness. Implementation strategies should include co-residing partners as key participants in household decision-making.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Saitoh A, Takaku M. Partner awareness and support for maternal RSV vaccination: a paired survey of pregnant women and co-residing partners in Japan. Vaccine. 2026. PMID: 42462679. doi:10.1016/j.vaccine.2026.128946

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。